Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,587 total articles
General Motors looks positioned for a clean, tradeable rally into and through the Q2 reporting window. The stock is trading near $82.90 with constructive technicals, a heavy free-cash-flow cushion ($14.76B trailing FCF) and renewed capital allocated to high-margin pickup production. I outline a specific swing trade (entry/stop/target), catalysts to…
Micron is trading near $1.08k after a massive run driven by AI demand for HBM and server DRAM. Fundamentals (EPS $21.38, FCF $10.28B) and a supply-constrained memory market support further upside, but the stock is richly priced and technically overbought. This trade idea lays out an actionable entry, stop, and target for a swing trade covering the …
Heritage Insurance (HRTG) pulled back after Q1 results that disappointed estimates. The stock now trades at single-digit P/E multiples, strong free cash flow and an attractive EV relative to sales. This trade idea lays out a disciplined long entry, stop and target with a mid-term horizon while highlighting the operational and market risks that coul…
Freightos (CRGO) has shown early signs of SaaS softness: price has slipped below key moving averages, short interest has crept up, and today's drop to $1.64 punctuates weakening momentum. I’m moving from a constructive stance to a tactical short with a defined entry, stop and targets over a mid-term horizon (45 trading days). This is a speculative …
Latham Group (SWIM) is a cash-generative pool manufacturer trading well below its 52-week high after a recent pullback. The company's acquisition of Freedom Pools and steady free cash flow support a near-term recovery. This trade targets a disciplined entry at $5.28, a $4.60 stop, and a $7.50 target over a mid-term horizon (45 trading days).
Rocket Lab has evolved beyond rideshare launches into spacecraft manufacturing, components and mission operations. With Q1 2026 revenue of $200M (63.5% YoY), a backlog north of $2B and Neutron on track for a maiden flight by end of 2026, the stock offers a high-risk, high-reward long trade. Entry at $115, stop $95, target $160 over a 180-trading-da…
Nu Holdings (NU) has compelling growth but the market is focused on two near-term storylines: a new CFO transition and signs of rising credit risk in Brazil. Technicals are weak and short activity is meaningful. For disciplined traders, a mid-term short with tight rules offers an asymmetric payoff while acknowledging the company's longer-term upsid…
First Community Corp (FCCO) trades below tangible book and at a low-teens P/E while generating positive free cash flow and paying a 2% dividend. With a conservative balance sheet (debt/equity ~0.07), modest short interest and recent technical support near the $30 area, FCCO is a pragmatic long candidate for traders willing to hold through a pending…
Apollo Global Management reported strong Q1 results and AUM above $1 trillion, while balance-sheet metrics and fees support valuation. Recent headlines about private credit deals have created an entry opportunity: buy at current levels with a clear stop and a 180-trading-day target of $150.
MercadoLibre tumbled after Q1 2026 results as management leaned into shipping subsidies, logistics and fintech expansion and operating margins compressed sharply. With revenue +49% YoY to $8.8B, GMV up 42% to $19B and fintech MAU at 83M, this pullback looks like a classic investment-cycle trough. We recommend a tactical long with a clear entry, sto…
Tourmaline Oil offers a compelling risk-reward for a mid-term long: the company’s low-cost Montney footprint, strong cash generation potential under higher gas prices, and shareholder-friendly capital allocation argue for upside, while the market appears to underappreciate durable free cash flow optionality. Target: $60.00, Entry: $45.00, Stop: $38…
MercadoLibre is investing aggressively to tie commerce, payments, credit and logistics together across Latin America. Recent earnings punished the stock as margins compressed, but revenue growth (+49% YoY in Q1) and 83M fintech MAUs argue the company is constructing a defensible digital ecosystem. This trade targets a rebound if margins recover and…
Constellium (CSTM) is a cyclical aluminum producer with advantaged exposure to aerospace, automotive lightweighting, and premium packaging. Recent operational discipline and improving cash flow give a cleaner risk/reward. This trade idea targets a mid-term entry with a clear stop and a defined upside target tied to normalization in demand and margi…
LOECF is an OTC-listed energy issuer trading at $0.67 with mixed technicals and heavy short activity. The case for a tactical long rests on management increasing the oil percentage of production at a time when oil sentiment is constructive. This is a high-risk, defined-entry swing trade designed to capture a re-rating or short-covering move over th…
Marvell's role in AI data-center networking is undeniable, but the stock has become a consensus trade after recent endorsements and upgrades. With a market cap north of $260B, a P/E near 100, and RSI in the mid-80s, we downgrade from constructive to a tactical short/sell-on-strength. Trade plan included for a mid-term (45 trading days) play.
Oportun (OPRT) trades at $4.73 with a market cap near $216M, P/B ~0.58 and P/E in the low teens. Recent ABS issuance and debt paydowns, plus growing engagement with its Set & Save product, suggest credit normalization and margin recovery are underway. For traders willing to accept mid-level credit and capital-structure risk, a tactical long targeti…
Microsoft combines durable cash flow, accelerating AI monetization, and best-in-class enterprise reach. The trade: enter $520.00, stop $480.00, target $600.00 over a 180 trading-day horizon.
ServiceNow's Now Platform is positioned as an enterprise 'control tower' for AI-driven workflows. Fundamentals show healthy free cash flow ($4.63B), low leverage (debt/equity 0.13), and solid returns (ROE ~15%), yet the stock trades near $120 with a P/E in the mid-70s after a recent pullback. This trade idea buys the dip with a disciplined stop whi…
Rocket Lab looks like a growth company that finally has the pieces in place to justify a higher multiple: $200M revenue in Q1 2026 (63.5% YoY), a backlog north of $2 billion, and a clear product roadmap culminating in the Neutron reusable rocket. The stock is trading at $115.85 with a market cap around $67.1B; this trade idea takes a constructive, …
ExlService has quietly built a data-and-AI-led operations stack that large insurers, healthcare payers, and enterprise finance teams are starting to adopt. The stock has been punished recently, offering a chance to play product-led AI adoption at a reasonable valuation; this trade idea lays out an entry at $29.55, a stop at $26.80 and a target of $…
Woodward's cross-vertical demand rebound, guidance lift and targeted M&A create a favorable setup. The chart looks constructive for a stake at current levels; take a disciplined long with a $352.56 entry, $410 target and $320 stop over a 180-trading-day horizon.
Microsoft's shares have pulled back into the $420s after a sharp selloff from the $555 high. Fundamentals - a $3.16T market cap, $72.9B in free cash flow, 30% return on equity - and constructive technicals argue for a mid-term rebound. I am initiating a long trade with a clear entry, stop and $500 target over the next 45 trading days.
TTM Technologies (TTMI) has delivered outsized revenue and profit beats as AI-driven data center buildouts lift demand for high-end printed circuit boards and backplanes. With Q1 strength, a manageable balance sheet and visible defense/space tailwinds, I recommend a long trade sized for a longer-duration swing: entry $180.00, stop $160.00, target $…
Credo just reported a Q4 where revenue alone eclipsed its prior full year and guided further growth into FY2027. The stock is a growth-forgiving valuation story on sales momentum, but the profit multiples are already rich. This trade idea buys the rally with a measured stop and a mid-term horizon to let revenue cadence and margin conversion materia…
Aura Biosciences is a clinical-stage oncology company trading near $6.84 with a market cap around $707M and roughly $5.08 in reported cash per share. Recent financing and management moves reduce near-term dilution risk and set up asymmetric upside if belzupacap sarotalocan (AU-011) posts positive data. This trade idea lays out an entry, stop and tw…
